We are live on
!
Find out more
CRB
Chad R. Baker Portfolio holdings
AUM
$620M
1-Year Est. Return
42.67%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$394M
AUM Growth
+$37.1M
(+10%)
Cap. Flow
+$5.11M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
45.14%
Holding
50
New
2
Increased
27
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$340K |
| 2 |
Carrier Global
CARR
|
+$326K |
| 3 |
Danaher
DHR
|
+$317K |
| 4 |
NVIDIA
NVDA
|
+$303K |
| 5 |
Apple
AAPL
|
+$269K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$3.57K |
| 2 |
Automatic Data Processing
ADP
|
+$3.38K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.85% |
| 2 | Healthcare | 18.66% |
| 3 | Industrials | 18.05% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Communication Services | 11.1% |
Similar funds
PLU
RR
TAIM
KGAMU
GPWA
MAC
BT
IC
Chad R. Baker's Q1 2023 Portfolio in Review
As of Q1 2023, Chad R. Baker held 50 positions worth $394M, up 10% from $357M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4%. Chad R. Baker opened 2 new positions and made no exits, leaving the 50-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Chad R. Baker's largest Q1 2023 buy was Novo Nordisk: 4,790 shares worth $381K.
- Chad R. Baker added most to Carrier Global in Q1 2023, an estimated $326K increase.
- Chad R. Baker's biggest Q1 2023 reduction was Procter & Gamble, cutting an estimated $3.57K.
- Chad R. Baker's ten largest holdings make up 45% of its $394M portfolio in Q1 2023.
- Chad R. Baker opened 2 new positions and closed 0 in Q1 2023.
- Chad R. Baker's portfolio value rose 10% quarter-over-quarter to $394M.
Based on Chad R. Baker's 13F filing for Q1 2023, filed 27 Apr 2023.